SCHEMBL2808278

SCHEMBL2808278

CC(=CSc1ccccc1)C(=Nc1ccc(Cl)cc1)Sc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.38
ALDH1A1 P00352 4/20 0.38
LMNA P02545 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
NOS3 P29474 5/20 0.37
NOS1 P29475 5/20 0.37
NOS2 P35228 4/20 0.37
TDP1 Q9NUW8 4/20 0.35
CYP2C19 P33261 3/20 0.35
KDM4E B2RXH2 3/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2D6 P10635 2/20 0.35
HTR3E A5X5Y0 2/20 0.35
HTR3B O95264 2/20 0.35
HTR3A P46098 2/20 0.35
HTR3D Q70Z44 2/20 0.35
HTR3C Q8WXA8 2/20 0.35
SLC22A2 O15244 1/20 0.35
SLC22A1 O15245 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2808276 1.00 MAPT (0.38) MAPTALDH1A1LMNANPSR1NOS3
SCHEMBL12850921 1.00 MAPT (0.38) MAPTALDH1A1LMNANPSR1NOS3
SCHEMBL2811196 0.96 MAPT (0.38) MAPTALDH1A1LMNANPSR1NOS3
SCHEMBL12850876 0.96 MAPT (0.38) MAPTALDH1A1LMNANPSR1NOS3
SCHEMBL2811197 0.96 MAPT (0.38) MAPTALDH1A1LMNANPSR1NOS3
SCHEMBL2811626 0.96 MAPT (0.38) MAPTALDH1A1LMNANPSR1NOS3
SCHEMBL12850838 0.96 MAPT (0.38) MAPTALDH1A1LMNANPSR1NOS3
SCHEMBL2811622 0.96 MAPT (0.38) MAPTALDH1A1LMNANPSR1NOS3
SCHEMBL2811371 0.94 NOS3 (0.36) MAPTALDH1A1LMNANPSR1NOS3
SCHEMBL12850943 0.94 NOS3 (0.36) MAPTALDH1A1LMNANPSR1NOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 MAPT 4608/4885ALDH1A1 405/4885LMNA 2201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.